Page 117 - The diagnostic work-up of women with postmenopausal bleeding

Cost-effectiveness
6
115
Figure 1. Study flowchart
Recurrent bleeding+
Recurrent bleeding - n=82
Therapeutic n=53 n= 3 no polyp, biopsy n= 5 polyp, biopsy
n= 45 polyp, polypectomy (n=6 inpatient)
Diagnostic n=34 n=34 no polyp
n= 18
Expectant management
Hysteroscopy n=98
n=87 hysteroscopy n=11 expectant
n=102
n=2 lost to follow-up
n= 100 included in follow-up
Expectant management
Expectant management
(Pre) cancer n=6
No (pre) cancer n=92
n=1
TVS+ sampling
Recurrent bleeding
n=4
Hysterectomy + BSO n=7
Recurrent bleeding + n= 18
Hysteroscopy +/-
polypectomy n=13 polypectomy n=9
Expectant management n=1
TVS+ sampling n= 4
Hysteroscopy +/- polypectomy n=13 polypectomy n=9 (inpatient n=4)
Expectant management
200 women with PMB
No (pre)cancer n=12
(Pre) cancer n=1
n=82